Project Grant R01DK134469

Award Date 7/15/24
Completion Date 6/30/28
Dollars Obligated $1.4M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Baton Rouge, LA 70808, USA
Similar Awards
The National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) awarded a $355,111 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the Pennington Biomedical Research Center in Baton Rouge, Louisiana. The 5-year grant, running from August 1, 2024 to June 30, 2029, will fund research to better define the mechanisms of the glycophagy shunt and its role in cellular metabolism. The research aims to enhance understanding of glycogen metabolism,...
This federal Project Grant award, valued at $450,000.00 and awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to elucidate the roles of the lysine acetyltransferase KAT8 in adipocyte function and its impact on lipoatrophy and systemic insulin resistance. The long-term objective is to understand how adipocyte KAT8 contributes to adipose tissue function and...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $115,949 to The Regents of the University of California, San Francisco (UCSF) to support research on the control of adipose immune-stromal niche topography in obesity. The primary objectives are to delineate adipose tissue topography using spatial sequencing, microscopy, and flow cytometry to identify novel signaling or cell...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $369,174 to Louisiana State University (LSU) to study the pathways of polyunsaturated fatty acid (PUFA) autoxidation and the cellular consequences. Specifically, the research aims to identify lipid electrophiles (LEs) formed through PUFA autoxidation, determine their PUFA and cellular pathway sources, and elucidate the...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will provide $1.2M over 5 years to support research at the University of Pennsylvania aimed at elucidating the molecular mechanisms of inflammasome activation and cytokine signaling in the innate immune system. The research will employ new tools to spatially and temporally map inflammasome formation and signaling, which is expected to...
This Project Grant award in the amount of $1,130,886.00 was issued by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The grant will fund research at The University of Texas Southwestern Medical Center on the molecular mechanisms underlying intracellular lipid sensing and metabolic regulation. Specifically, the project aims to define how the nuclear hormone receptor NHR-49 is activated and attenuated in...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), provides $484,625 to The Washington University in St. Louis to conduct research on the spatiotemporal regulation of organelle interactions and metabolism. The primary objectives are to biophysically and structurally define how lipolytic complexes are assembled and regulated on the surface of lipid droplets, use optical biosensors...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will provide approximately $107,987 to the Pennington Biomedical Research Center in Baton Rouge, Louisiana over a 5-year period from Sep 1, 2024 to Aug 31, 2029. The purpose of this grant is to host an annual 5-day "Clinical Methods for Nutrition and Obesity Research" course...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $450,252 to Oklahoma State University to conduct research on glial cell dysfunction and its role in obesity-induced hypertension and sympathetic nervous system overactivity. The key objectives of the 5-year project are to: 1) determine the mechanistic role of senescent microglial cells and their secretory phenotype on sympathetic...
This federal Project Grant award in the amount of $640,762.00 was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, with a start date of September 15, 2024 and an ultimate completion date of June 30, 2029, will fund research conducted by the Scripps Research Institute in La Jolla, California to investigate the interorgan communication mechanisms between...

This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $1,400,000.00 to the Pennington Biomedical Research Center in Baton Rouge, Louisiana to support research on the role of adipocyte cytokine signaling in regulating adipose tissue function and inflammation.

The research aims to address knowledge gaps in the mechanisms by which adipocytes regulate adipose tissue inflammation to maintain insulin sensitivity, with a focus on the cytokine oncostatin M (OSM) and its receptor (OSMR). Specifically, the project will test hypotheses that continued exposure of adipocytes to OSM leads to OSMR desensitization, excess stromal-derived factor 1 (SDF1) secretion, and adipocyte insulin resistance, and that excess SDF1 and OSM act on macrophages and preadipocytes to promote adipose tissue inflammation. The award has an initial project period from July 2024 through June 2028.

Generated 7/1/25, 3:23 AM